Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
University of Alabama at Birmingham
University of Alabama at Birmingham
Mayo Clinic
Alliance Foundation Trials, LLC.
University of Louisville
Case Comprehensive Cancer Center
Mayo Clinic
University of California, Irvine
Sun Yat-sen University
Sun Yat-sen University
The Netherlands Cancer Institute
Rutgers, The State University of New Jersey
Sichuan Enray Pharmaceutical Sciences Company
University of Chicago
M.D. Anderson Cancer Center
University of Florida
Essen Biotech
Essen Biotech
University of Pittsburgh
Grey Wolf Therapeutics
University of Chicago
Washington University School of Medicine
Hospices Civils de Lyon
Hospices Civils de Lyon
M.D. Anderson Cancer Center
Seoul National University Hospital
ARCAGY/ GINECO GROUP
Icahn School of Medicine at Mount Sinai
Mayo Clinic
Radboud University Medical Center
University of Arizona
Maastricht University Medical Center
Hadassah Medical Organization
Hospices Civils de Lyon
Hadassah Medical Organization
Institut Curie
Shenzhen Geno-Immune Medical Institute
Instituto do Cancer do Estado de São Paulo
Centre Leon Berard
Jonsson Comprehensive Cancer Center
Herlev Hospital
Cancer Research UK
Anhui Provincial Cancer Hospital
NuCana plc
Essen Biotech
University of California, Irvine
Roswell Park Cancer Institute
Zuyderland Medisch Centrum
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Cancer Research UK